A synthetic peptide, Bremelanotide PT 141, treats sexual dysfunction for both female sexual dysfunction and male erectile dysfunction
10mg vial / 8mg per week = 1.25 weeks
On the contrary, most lncRNAs targeting c-Met compete for endogenous RNAs (ceRNAs), decoys, or sponges, and combine with specific miRNAs to prevent the inhibition of c-Met, including ceRNAs: lnc-XIST, lnc-MALAT1, lnc-GAPLINC, lnc-HOTAIR targeting miR-34 (Md Yusof et al., 2020), LINC00240 targeting miR-4465 (Yang and Chen, 2019), etc
The material is intended for experimental use only and does not imply human or animal benefit
Will they be added to the 503A Bulks Lists